GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Other Current Liabilities

FibroBiologics (STU:SG0) Other Current Liabilities : €0.50 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Other Current Liabilities?

FibroBiologics's other current liabilities for the quarter that ended in Mar. 2025 was €0.50 Mil.

FibroBiologics's quarterly other current liabilities declined from Sep. 2024 (€2.82 Mil) to Dec. 2024 (€0.44 Mil) but then increased from Dec. 2024 (€0.44 Mil) to Mar. 2025 (€0.50 Mil).

FibroBiologics's annual other current liabilities increased from Dec. 2022 (€0.51 Mil) to Dec. 2023 (€6.64 Mil) but then declined from Dec. 2023 (€6.64 Mil) to Dec. 2024 (€0.44 Mil).


FibroBiologics Other Current Liabilities Historical Data

The historical data trend for FibroBiologics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Other Current Liabilities Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
- 0.51 6.64 0.44

FibroBiologics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.51 5.87 2.82 0.44 0.50

FibroBiologics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


FibroBiologics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics Business Description

Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

FibroBiologics Headlines

No Headlines